Transperineal interstitial implantation of prostate cancer: a new method

A method of transperineal interstitial implant of prostate without the need for surgical exploration was used to provide a boost dose of 3200 rad to the implanted volume in patients with relatively advanced Stage C carcinoma of the prostate. All patients were initially given megavoltage teletherapy to a dose of 4320 rad in 24 treatments. Disease was locally controlled among all patients except one (96%). The morbitity was insignificant and the quality of life was good. The time of recurrence was from three to nine months in the seven patients who failed. No patient among those initially diagnosed by needle biopsy had failed whereas 50% of those whose diagnosis was by transurethral resection showed distant metastases